ILMN - NASDAQ
Illumina, Inc.
$170.93
+5.2%Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
At a Glance
Live SnapshotIllumina, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.
Cash Flow Quality Insight
Exceptional cash generation: High-quality earnings converting to growing free cash flow. The company demonstrates strong pricing power, efficient operations, and disciplined capital allocation.
Illumina, Inc. Cash Flow Statement
ILMN • NASDAQ
| Illumina, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Jan 2023 | Jan 2022 | Jan 2021 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||||||
850M | -1.2B | -1.2B | -4.4B | 762M | 656M | 990M | 782M | 678M | 428.1M | 457.4M | 353.4M | 125.3M | 151.3M | 86.6M | 124.9M | 72.3M | 50.5M | -278.4M | 40M | |
270M | 354M | 432M | 394M | 251M | 187M | 188M | 179M | 156M | 140.9M | 126.4M | 112.6M | 97.9M | 63.8M | 68.3M | 42M | 31.2M | 28.9M | 15.8M | 5.7M | |
119M | -112M | -33M | -23M | -76M | 117M | 11M | -18M | 81M | 93.6M | 80.5M | 99.8M | -36.7M | -21.7M | -27.1M | 48.7M | 29.7M | 38.7M | -11.4M | -548K | |
0.0 | 370M | 380M | 366M | 754M | 194M | 194M | 193M | 164M | 129.1M | 132.6M | 152.6M | 105.8M | 94.3M | 92.1M | 71.6M | 60.8M | 47.7M | 33.7M | 14.3M | |
-7M | 1.9B | 950M | 3.9B | -994M | -147M | -138M | 24M | -399M | -59.4M | -98.9M | -160.6M | -59.4M | 22.2M | 101.3M | -12.5M | -8.2M | 10.5M | 283.3M | -1.3M | |
(0.0) | (105M) | (65M) | (122M) | (233M) | (119M) | (164M) | (99M) | (149M) | (60M) | (17M) | (17.9M) | (50.1M) | (74M) | (9.8M) | (31.6M) | (10.4M) | (1.7M) | (0.0) | (0.0) | |
-153M | -483M | -90M | 204M | -152M | 73M | -194M | -18M | 195M | -45M | -38.4M | -56.5M | 153.4M | -18M | 37M | -2.1M | -11.3M | -88.4M | 13.2M | -19.1M | |
1.1B | 837M | 478M | 392M | 545M | 1.1B | 1.1B | 1.1B | 875M | 687.2M | 659.6M | 501.3M | 386.4M | 291.9M | 358.1M | 272.6M | 174.5M | 87.9M | 56.3M | 39M | |
INVESTING ACTIVITIES | ||||||||||||||||||||
-158M | -128M | -195M | -286M | -208M | -189M | -209M | -296M | -312M | -271.4M | -143.2M | -142.2M | -90.6M | -81M | -79.6M | -56.5M | -55.2M | -95.7M | -24.4M | -15.2M | |
(0.0) | (2M) | -29M | -265M | -2.4B | -98M | -32M | -100M | -52M | -17.8M | -36.6M | -3.3M | -427.9M | -32.3M | -58.3M | -98.2M | -1.3M | -24.7M | (72.1M) | -50M | |
(0.0) | -52M | -6M | -40M | -77M | -1.9B | -1B | -2.9B | -771M | -908.2M | -803.1M | -803M | -364M | -941.4M | -1.3B | -873.9M | -714.4M | -568.7M | -598.4M | -239.4M | |
103M | 0.0 | 0.0 | 0.0 | 1.7B | 1.8B | 2B | 1.5B | 921M | 682.9M | 876.8M | 541.9M | 812.8M | 898.8M | 1.1B | 743.5M | 515.2M | 411.8M | 483M | 143.8M | |
0.0 | 0.0 | -1M | 0.0 | 0.0 | -132M | 0.0 | -1.4B | 96M | -237M | 73M | -297.3M | 533.1M | 6M | -401M | -285.1M | -255.7M | -60.7M | 42K | -53.1M | |
-55M | -178M | -231M | -591M | -1.1B | -554M | (745M) | -1.8B | -214M | -514.5M | -106.1M | -406.6M | -69.6M | -150M | -401M | -285.1M | -255.7M | -277.2M | -67.7M | -160.7M | |
FINANCING ACTIVITIES | ||||||||||||||||||||
-698M | -60M | 67M | 63M | 60M | -675M | -265M | -155M | -180M | -202M | -202M | -140.9M | 44.4M | -28.2M | -508.5M | 58M | -135.8M | 316.2M | -122.9M | 108M | |
-5M | 491M | -1.2B | 991M | 471M | 0.0 | -550M | 731M | -4M | -61M | -245M | -142.3M | -10.9M | 0.0 | 553.6M | 0.0 | -10M | -15K | 251.1M | -109K | |
-742M | -116M | (0.0) | (0.0) | (0.0) | -736M | -324M | -201M | -251M | -249M | -274.3M | -237.2M | -50M | -82.5M | -570.4M | -44M | -175.1M | -70.8M | -251.6M | (0.0) | |
-41M | -1B | -42M | -54M | -582M | -91M | -82M | 138M | 8M | -33.3M | -3.9M | 116.4M | -72.3M | 17.4M | 51.9M | 58.5M | 46.9M | 21.5M | 20.1M | 1.4M | |
-744M | -570M | -1.2B | 1B | -51M | -766M | -897M | 594M | -176M | -204.7M | -418.8M | -166.7M | -38.7M | -10.8M | 97M | 116.5M | -98.9M | 337.7M | 148.3M | 109.3M | |
CASH FLOW SUMMARY | ||||||||||||||||||||
11M | -10M | 0.0 | -22M | -3M | 8M | -1M | -4M | 5M | -2.2M | -2.1M | -3.4M | -397K | -103K | -126K | 320K | -2.3M | 3.8M | -345K | 3K | |
291M | 79M | -963M | 779M | -578M | -232M | 898M | -81M | 490M | -34.3M | 132.6M | -75.5M | 277.7M | 131M | 54M | 104.3M | -182.4M | 152.1M | 136.6M | -12.4M | |
1.1B | 1B | 2B | 1.2B | 1.8B | 2B | 1.1B | 1.2B | 735M | 768.8M | 636.2M | 711.6M | 434M | 303M | 248.9M | 144.6M | 327M | 174.9M | 38.4M | 50.8M | |
1.4B | 1.1B | 1B | 2B | 1.2B | 1.8B | 2B | 1.1B | 1.2B | 734.5M | 768.8M | 636.2M | 711.6M | 434M | 303M | 248.9M | 144.6M | 327M | 174.9M | 38.4M | |
931M | 709M | 282M | 106M | 337M | 891M | 842M | 846M | 563M | 415.9M | 516.3M | 359.1M | 295.9M | 210.9M | 278.6M | 216.1M | 119.3M | -7.8M | 31.9M | 23.8M |
SEC Filings
ILMN - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 26, 2026 | May 21, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 04, 2026 | March 29, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 09, 2026 | May 21, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 02, 2026 | April 02, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 12, 2026 | December 28, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 05, 2026 | February 05, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 30, 2026 | January 30, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 13, 2026 | January 13, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 08, 2026 | January 08, 2026 | 2026 |
Related Guides
Continue your ILMN research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.